2 Results Sort by:
Combination of Tetrahydrobiopterin and Arginine/ ± Arginase Inhibitors for the Treatment of COVID-19
­ Application A novel drug combination to address acute arginine/BH4 dysregulation that develops with COVID-19 and MIS-C infection. Key Benefits Potential to improve outcomes of those infected with COVID-19 with few side effects. Repurposing opportunity with the combination of two approved drugs (tetrahydrobiopterin and arginine). Addresses...
Published: 4/23/2024       Contributor(s): Claudia Morris, Lou Ann Brown
A Nutritional Therapy for Autism/Apraxia and Malabsorption
Application An elemental dietary supplement for treating autism, apraxia and malabsorption syndrome to reverse and avoid nutritional deficiencies. Key Benefits Provides a complete elemental dietary supplement with the proper dosage of nutrients for children with the syndrome of allergy, apraxia, and malabsorption. Potential treatment for neuro...
Published: 4/23/2024       Contributor(s): Claudia Morris